Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

16

Revenue 2017

Tecfidera

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Tecfidera was produced by Biogen Idec.

CHMP October meeting gives recommendations for Pfizer and MSD

CHMP October meeting gives recommendations for Pfizer and MSD But the regulatory advisors sound note ofcaution on Biogen’s Tecfidera. The Committee for Medicinal Products for Human Use (CHMP) recommended European approval for Amgen's Imlygic for melanoma and also ... New advice has also been issued on the use of

Executive vice president of Biogen leaves

Executive vice president of Biogen leaves Kingsley joined Biogen in 2010 as senior VP and during his tenure Biogen introduced five new therapies including successfully launching Tecfidera (dimethyl fumarate) – the most prescribed oral treatment for multiple sclerosis.

Biogen cuts workforce and culls pipeline projects

Biogen cuts workforce and culls pipeline projects Some of the money saved has been earmarked for a renewed promotional push for oral MS therapy Tecfidera (dimethyl glutamate), which achieved sales of $937m in the third-quarter, a rise ... Tecfidera's success depends on Biogen persuading patients on

Sanofi posts positive data for MS drug Aubagio

Sanofi posts positive data for MS drug Aubagio Additionally, competition also comes from Biogen Idec's Tecfidera (dimethyl fumarate), which managed to sell three times more in 8 months than Aubagio managed in a full year.

Novartis buys rights to GSK's Arzerra in MS for $1bn

Novartis buys rights to GSK's Arzerra in MS for $1bn s oral drug Tecfidera (dimethyl glutamate) and Novartis' own Gilenya (fingolimod).

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
...
Patients are ready for virtual clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...

Infographics